Peritoneal tuberculosis complicated by immune reconstitution inflammatory syndrome in a patient treated with infliximab?: a case for adjuvant immunosuppressive therapy.
Szerszen
Anita
A
Division of Geriatrics, Department of Medicine, Staten Island University Hospital, Staten Island, NY 10309, USA. aszerszen@aol.com
Gupta
Shilpi
S
Seminara
Donna
D
Jarrett
Mark
M
Goldstein
Mark
M
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000150:complications* / Q000188:drug therapy; D007155:Immunologic Factors / Q000009:adverse effects*; D000069285:Infliximab; D008297:Male; D014395:Peritonitis, Tuberculous / Q000150:complications*; D011241:Prednisone / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D000069285:Infliximab; D011241:Prednisone